Marta Relvas‐Santos

681 total citations
17 papers, 466 citations indexed

About

Marta Relvas‐Santos is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Marta Relvas‐Santos has authored 17 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Immunology and 3 papers in Oncology. Recurrent topics in Marta Relvas‐Santos's work include Glycosylation and Glycoproteins Research (16 papers), RNA modifications and cancer (4 papers) and Galectins and Cancer Biology (4 papers). Marta Relvas‐Santos is often cited by papers focused on Glycosylation and Glycoproteins Research (16 papers), RNA modifications and cancer (4 papers) and Galectins and Cancer Biology (4 papers). Marta Relvas‐Santos collaborates with scholars based in Portugal, United Kingdom and Spain. Marta Relvas‐Santos's co-authors include José Alexandre Ferreira, Lúcio Lara Santos, Andreia Peixoto, Rita Azevedo, Luís Lima, Cristiana Gaiteiro, Dylan Ferreira, André M. N. Silva, Elisabete Fernandes and Carlos Palmeira and has published in prestigious journals such as ACS Nano, International Journal of Molecular Sciences and Journal of Controlled Release.

In The Last Decade

Marta Relvas‐Santos

16 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Relvas‐Santos Portugal 9 354 172 98 57 56 17 466
Dylan Ferreira Portugal 15 318 0.9× 154 0.9× 114 1.2× 32 0.6× 82 1.5× 24 486
Pedro Enrique Guerrero Spain 10 246 0.7× 144 0.8× 126 1.3× 31 0.5× 54 1.0× 17 389
Henrique O. Duarte Portugal 11 317 0.9× 139 0.8× 101 1.0× 32 0.6× 91 1.6× 23 454
Frank Leon United States 7 299 0.8× 118 0.7× 151 1.5× 44 0.8× 83 1.5× 8 420
Keiichiro Sakuma Japan 11 404 1.1× 165 1.0× 126 1.3× 46 0.8× 89 1.6× 19 567
Sofia Cotton Portugal 10 191 0.5× 88 0.5× 65 0.7× 26 0.5× 54 1.0× 14 304
Marzena Cydzik Canada 14 252 0.7× 137 0.8× 110 1.1× 44 0.8× 26 0.5× 17 462
Marta Pérez-Garay Spain 7 317 0.9× 190 1.1× 67 0.7× 47 0.8× 34 0.6× 9 363
Johan F. A. Pijnenborg Netherlands 8 366 1.0× 206 1.2× 91 0.9× 31 0.5× 27 0.5× 12 446
Irina Häuselmann Switzerland 3 291 0.8× 180 1.0× 92 0.9× 54 0.9× 47 0.8× 3 378

Countries citing papers authored by Marta Relvas‐Santos

Since Specialization
Citations

This map shows the geographic impact of Marta Relvas‐Santos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Relvas‐Santos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Relvas‐Santos more than expected).

Fields of papers citing papers by Marta Relvas‐Santos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Relvas‐Santos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Relvas‐Santos. The network helps show where Marta Relvas‐Santos may publish in the future.

Co-authorship network of co-authors of Marta Relvas‐Santos

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Relvas‐Santos. A scholar is included among the top collaborators of Marta Relvas‐Santos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Relvas‐Santos. Marta Relvas‐Santos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Relvas‐Santos, Marta, Dylan Ferreira, Andreia Brandão, et al.. (2025). Glycomics and Glycoproteomics Reveal Distinct Oligomannose Carriers Across Bladder Cancer Stages. International Journal of Molecular Sciences. 26(10). 4891–4891.
2.
Ferreira, Dylan, Marta Relvas‐Santos, Flávia Castro, et al.. (2024). Targeted and Self-Adjuvated Nanoglycovaccine Candidate for Cancer Immunotherapy. ACS Nano. 18(14). 10088–10103. 4 indexed citations
3.
Ferreira, Dylan, Marta Relvas‐Santos, Janine Soares, et al.. (2024). Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer. International Journal of Molecular Sciences. 25(6). 3462–3462. 1 indexed citations
4.
Soares, Janine, Dylan Ferreira, Marta Relvas‐Santos, et al.. (2024). Stool Glycoproteomics Signatures of Pre-Cancerous Lesions and Colorectal Cancer. International Journal of Molecular Sciences. 25(7). 3722–3722. 4 indexed citations
5.
Ferreira, Dylan, Marta Relvas‐Santos, Flávia Castro, et al.. (2024). A multivalent CD44 glycoconjugate vaccine candidate for cancer immunotherapy. Journal of Controlled Release. 367. 540–556. 7 indexed citations
6.
Cotton, Sofia, Dylan Ferreira, Marta Relvas‐Santos, et al.. (2024). E‐selectin affinity glycoproteomics reveals neuroendocrine proteins and the secretin receptor as a poor‐prognosis signature in colorectal cancer. Molecular Oncology. 19(3). 635–658. 1 indexed citations
7.
Gaiteiro, Cristiana, Janine Soares, Marta Relvas‐Santos, et al.. (2022). Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion. Theranostics. 12(7). 3150–3177. 29 indexed citations
8.
Ferreira, José Alexandre, Marta Relvas‐Santos, Andreia Peixoto, André M. N. Silva, & Lúcio Lara Santos. (2021). Glycoproteogenomics: Setting the Course for Next-Generation Cancer Neoantigen Discovery for Cancer Vaccines. Genomics Proteomics & Bioinformatics. 19(1). 25–43. 19 indexed citations
9.
Cotton, Sofia, Dylan Ferreira, Janine Soares, et al.. (2021). Target Score—A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness. International Journal of Molecular Sciences. 22(4). 1664–1664. 14 indexed citations
10.
Peixoto, Andreia, Dylan Ferreira, Rita Azevedo, et al.. (2021). Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer. Journal of Experimental & Clinical Cancer Research. 40(1). 191–191. 25 indexed citations
11.
Relvas‐Santos, Marta, Rita Azevedo, Janine Soares, et al.. (2021). Single-pot enzymatic synthesis of cancer-associated MUC16 O-glycopeptide libraries and multivalent protein glycoconjugates: a step towards cancer glycovaccines. New Journal of Chemistry. 45(20). 9197–9211. 7 indexed citations
12.
Fernandes, Elisabete, Dylan Ferreira, Janine Soares, et al.. (2020). Nucleolin-SLe <sup>A</sup> Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells. SSRN Electronic Journal. 4 indexed citations
13.
Fernandes, Elisabete, Dylan Ferreira, Janine Soares, et al.. (2020). Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells. Cancers. 12(4). 861–861. 20 indexed citations
14.
Peixoto, Andreia, Marta Relvas‐Santos, Rita Azevedo, Lúcio Lara Santos, & José Alexandre Ferreira. (2019). Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks. Frontiers in Oncology. 9. 380–380. 232 indexed citations
15.
Fernandes, Elisabete, Dylan Ferreira, Andreia Peixoto, et al.. (2019). Glycoengineered nanoparticles enhance the delivery of 5-fluoroucil and paclitaxel to gastric cancer cells of high metastatic potential. International Journal of Pharmaceutics. 570. 118646–118646. 33 indexed citations
16.
Azevedo, Rita, Cristiana Gaiteiro, Andreia Peixoto, et al.. (2018). CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications. Clinical Proteomics. 15(1). 22–22. 40 indexed citations
17.
Azevedo, Rita, Janine Soares, Cristiana Gaiteiro, et al.. (2018). Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer. Talanta. 184. 347–355. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dylan Ferreira Breakdown of academic impact, for papers by Pedro Enrique Guerrero Breakdown of academic impact, for papers by Henrique O. Duarte Breakdown of academic impact, for papers by Frank Leon Breakdown of academic impact, for papers by Keiichiro Sakuma Breakdown of academic impact, for papers by Sofia Cotton Breakdown of academic impact, for papers by Marzena Cydzik Breakdown of academic impact, for papers by Marta Pérez-Garay Breakdown of academic impact, for papers by Johan F. A. Pijnenborg Breakdown of academic impact, for papers by Irina Häuselmann
Rankless by CCL
2026